(firstQuint)The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers.

 The study is a randomized, double-blind phase 1 trial including 3 independent parts: single ascending dose(SAD) part,multiple ascending dose(MAD) part and postprandial pharmacokinetics part.

 SAD and MAD are dose-escalated tolerant study designed 8 cohorts and 5 cohorts in SAD and MAD respectively.

 The aims of the study as below: 1.

 Evaluating the safety and tolerance of Jaktinib in healthy volunteers.

 2.

 Evaluating the fasting pharmacokinetic parameters of Jaktinib in healthy volunteers.

 3.

 Evaluating the postprandial pharmacokinetic parameters of jaktinib in healthy volunteers.

 4.

 Analysis the metabolites of Jaktinib.

 The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers@highlight

A randomized, double-blinding, dose-escalated phase 1 trial to evaluate the tolerance and fasting/postprandial pharmacokinetics of jaktinib.

